-
Je něco špatně v tomto záznamu ?
Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin
M. Sicking, M. Živná, P. Bhadra, V. Barešová, A. Tirincsi, D. Hadzibeganovic, K. Hodaňová, P. Vyleťal, J. Sovová, I. Jedličková, M. Jung, T. Bell, V. Helms, AJ. Bleyer, S. Kmoch, A. Cavalié, S. Lang
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2018
Freely Accessible Science Journals
od 2018
PubMed Central
od 2018
ROAD: Directory of Open Access Scholarly Resources
od 2018
PubMed
35064074
DOI
10.26508/lsa.202101150
Knihovny.cz E-zdroje
- MeSH
- endoplazmatické retikulum metabolismus MeSH
- fenylbutyráty metabolismus farmakologie MeSH
- HEK293 buňky MeSH
- lidé MeSH
- missense mutace MeSH
- molekulární chaperony metabolismus MeSH
- nemoci ledvin patofyziologie MeSH
- polycystická choroba ledvin MeSH
- renin genetika metabolismus MeSH
- sarkoplazmatická Ca2+-ATPáza metabolismus MeSH
- translokační kanály SEC chemie genetika metabolismus MeSH
- transport proteinů genetika MeSH
- vápník metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The human Sec61 complex is a widely distributed and abundant molecular machine. It resides in the membrane of the endoplasmic reticulum to channel two types of cargo: protein substrates and calcium ions. The SEC61A1 gene encodes for the pore-forming Sec61α subunit of the Sec61 complex. Despite their ubiquitous expression, the idiopathic SEC61A1 missense mutations p.V67G and p.T185A trigger a localized disease pattern diagnosed as autosomal dominant tubulointerstitial kidney disease (ADTKD-SEC61A1). Using cellular disease models for ADTKD-SEC61A1, we identified an impaired protein transport of the renal secretory protein renin and a reduced abundance of regulatory calcium transporters, including SERCA2. Treatment with the molecular chaperone phenylbutyrate reversed the defective protein transport of renin and the imbalanced calcium homeostasis. Signal peptide substitution experiments pointed at targeting sequences as the cause for the substrate-specific impairment of protein transport in the presence of the V67G or T185A mutations. Similarly, dominant mutations in the signal peptide of renin also cause ADTKD and point to impaired transport of this renal hormone as important pathogenic feature for ADTKD-SEC61A1 patients as well.
Center for Bioinformatics Saarland University Saarbrücken Germany
Department of Chemistry University of Nevada Reno NV USA
Department of Medical Biochemistry and Molecular Biology Saarland University Homburg Germany
Section on Nephrology Wake Forest School of Medicine Winston Salem NC USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011281
- 003
- CZ-PrNML
- 005
- 20220506131458.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.26508/lsa.202101150 $2 doi
- 035 __
- $a (PubMed)35064074
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sicking, Mark $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany
- 245 10
- $a Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin / $c M. Sicking, M. Živná, P. Bhadra, V. Barešová, A. Tirincsi, D. Hadzibeganovic, K. Hodaňová, P. Vyleťal, J. Sovová, I. Jedličková, M. Jung, T. Bell, V. Helms, AJ. Bleyer, S. Kmoch, A. Cavalié, S. Lang
- 520 9_
- $a The human Sec61 complex is a widely distributed and abundant molecular machine. It resides in the membrane of the endoplasmic reticulum to channel two types of cargo: protein substrates and calcium ions. The SEC61A1 gene encodes for the pore-forming Sec61α subunit of the Sec61 complex. Despite their ubiquitous expression, the idiopathic SEC61A1 missense mutations p.V67G and p.T185A trigger a localized disease pattern diagnosed as autosomal dominant tubulointerstitial kidney disease (ADTKD-SEC61A1). Using cellular disease models for ADTKD-SEC61A1, we identified an impaired protein transport of the renal secretory protein renin and a reduced abundance of regulatory calcium transporters, including SERCA2. Treatment with the molecular chaperone phenylbutyrate reversed the defective protein transport of renin and the imbalanced calcium homeostasis. Signal peptide substitution experiments pointed at targeting sequences as the cause for the substrate-specific impairment of protein transport in the presence of the V67G or T185A mutations. Similarly, dominant mutations in the signal peptide of renin also cause ADTKD and point to impaired transport of this renal hormone as important pathogenic feature for ADTKD-SEC61A1 patients as well.
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a endoplazmatické retikulum $x metabolismus $7 D004721
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nemoci ledvin $x patofyziologie $7 D007674
- 650 _2
- $a molekulární chaperony $x metabolismus $7 D018832
- 650 _2
- $a missense mutace $7 D020125
- 650 _2
- $a fenylbutyráty $x metabolismus $x farmakologie $7 D010654
- 650 _2
- $a polycystická choroba ledvin $7 D007690
- 650 _2
- $a transport proteinů $x genetika $7 D021381
- 650 _2
- $a renin $x genetika $x metabolismus $7 D012083
- 650 _2
- $a translokační kanály SEC $x chemie $x genetika $x metabolismus $7 D000069816
- 650 _2
- $a sarkoplazmatická Ca2+-ATPáza $x metabolismus $7 D053498
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Bhadra, Pratiti $u Center for Bioinformatics, Saarland University, Saarbrücken, Germany
- 700 1_
- $a Barešová, Veronika $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Tirincsi, Andrea $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany $1 https://orcid.org/0000000208898340
- 700 1_
- $a Hadzibeganovic, Drazena $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany
- 700 1_
- $a Hodaňová, Kateřina $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Vyleťal, Petr $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Sovová, Jana $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Jedličková, Ivana $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Jung, Martin $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany $1 https://orcid.org/0000000214827020
- 700 1_
- $a Bell, Thomas $u Department of Chemistry, University of Nevada, Reno, NV, USA
- 700 1_
- $a Helms, Volkhard $u Center for Bioinformatics, Saarland University, Saarbrücken, Germany $1 https://orcid.org/0000000221809154
- 700 1_
- $a Bleyer, Anthony J $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA
- 700 1_
- $a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Cavalié, Adolfo $u Experimental and Clinical Pharmacology and Toxicology, Pre-clinical Center for Molecular Signaling (PZMS), Saarland University, Homburg, Germany
- 700 1_
- $a Lang, Sven $u Department of Medical Biochemistry and Molecular Biology, Saarland University, Homburg, Germany sven.lang@uni-saarland.de $1 https://orcid.org/0000000313261851
- 773 0_
- $w MED00197314 $t Life science alliance $x 2575-1077 $g Roč. 5, č. 4 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35064074 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131450 $b ABA008
- 999 __
- $a ok $b bmc $g 1789065 $s 1162479
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 5 $c 4 $e 20220121 $i 2575-1077 $m Life science alliance $n Life sci. alliance $x MED00197314
- LZP __
- $a Pubmed-20220425